Embilio Pharma International GmbH is a newly established German pharmaceutical
company representing a century of experience in the global pharmaceutical industry. It
is a product of the fourth generation of the Embil family, the success story of which was
started in the back room of a pharmacy in the small Turkish town of Bandirma, Turkey in
1921 and continued in Istanbul with great success for many years.
The name Embil carries the meaning of ‘Knowledge of Medicine’ in Turkish, emphasizing the historic heritage of the family in the pharmaceutical field.
Embil Pharmaceutical was a unique company, developing technologically-superior, original products for the global market with a highly modernized manufacturing facility for semi-solid pharmaceuticals. The company’s products were used in the fields of obstetrics & gynecology, dermatology, rheumatology, neurology and family planning. In 2014 Embil Pharmaceutical was sold to the Spanish Chemo group.
In order to continue the Pharmaceutical Science heritage of previous generations and to use its longstanding experience with specialized niche products, Embilio Pharma International GmbH was founded in Germany in 2018 by Koral Embil, PhD, a scientist and inventor of numerous pharmaceutical products.